Advertisement
Screener

Immunocore Holdings plc (IMCR) Material Contracts

Immunocore Holdings plc Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2025-02-26: Form 10-K; Exhibit 10.17; Description Form of Restricted Share Unit Agreement under 2021 Equity Incentive Plan.
  • 2025-02-26: Form 10-K; Exhibit 10.9; Description Employment Agreement between the Registrant and Travis Coy, dated December 31, 2024.
  • 2024-05-28: Form 8-K; Exhibit 10.2; Description Registration Rights Agreement, dated May 28, 2024, by and among the Company and 667, L.P. and Baker Brothers Life Sciences, L.P..
  • 2024-05-28: Form 8-K; Exhibit 10.1; Description Amendment No. 1 to Letter Agreement by and among the Company and 667, L.P. and Baker Brothers Life Sciences, L.P., dated February 6, 2024..
FiledFormExhibitDescription
2025-02-2610-K10.17Form of Restricted Share Unit Agreement under 2021 Equity Incentive Plan
2025-02-2610-K10.9Employment Agreement between the Registrant and Travis Coy, dated December 31, 2024
2024-05-288-K10.2Registration Rights Agreement, dated May 28, 2024, by and among the Company and 667, L.P. and Baker Brothers Life Sciences, L.P.
2024-05-288-K10.1Amendment No. 1 to Letter Agreement by and among the Company and 667, L.P. and Baker Brothers Life Sciences, L.P., dated February 6, 2024.
2024-02-2810-K10.14Employment Agreement between the Registrant and Tina St Leger, dated August 2, 2021
2024-02-2810-K10.13Employment Agreement between the Registrant and David Berman, MD., Ph.D., dated January 29, 2021
2024-02-2810-K10.2Employment Agreement between the Registrant and Brian Di Donato, dated January 29, 2021

Similar stocks

Stock NameCountryMarket CapPE Ratio
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Vericel Corp (VCEL)United States$2.011B93.97
Replimune Group, Inc. (REPL)United States$1.186B-3.13
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12